The effects of neuromuscular alterations in elders with cancer

Seminars in Oncology Nursing

Volumn 22, Issue 1, 2006, Pages 36-42

  Visovsky, Constance ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 31744450491     PISSN: 07492081     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soncn.2005.10.010     Document Type: Article

References (45)

1. L. Repetto, D. Comandini Cancer in the elderly Assessing patients for fitness Crit Rev Oncol Hematol 35 2000 155 160
2. R. Yancik, L.A. Ries Aging and cancer in America. Demographic and epidemiologic perspectives Hematol Oncol Clin North Am 14 2000 17 23
3. J. Yates Comorbidity considerations in geriatric oncology research CA Cancer J Clin 51 2001 329 336
4. J.H. Peters, G.R. Gordon, D. Kashiwase Tissue distribution of doxorubicin and doxorubicinol in rats receiving multiple doses of doxorubicin Cancer Chemother Pharmacol 7 1981 65 69
5. D. Bagchi, M. Bagchi, E. Hassoun Adriamycin-induced hepatic and myocardial lipid peroxidation and DNA damage, and enhanced excretion of urinary lipid metabolites in rats Toxicology 95 1995 1 9
6. E. Verdu, D. Ceballos, J.J. Vilches Influence of aging on peripheral nerve function and regeneration J Peripher Nerv Syst 5 2000 191 208
7. P.J. Dyck, J. Karnes, P. O'Brien Spatial pattern of nerve fiber abnormality indicative of pathologic mechanism Am J Pathol 117 1984 225 238
8. X. Navarro, W.R. Kennedy, D.E. Sutherland Autonomic neuropathy and survival in diabetes mellitus Effects of pancreas transplantation Diabetologia 34 suppl 1 1991 S108 S112
9. K.J. Collins, A.N. Exton-Smith, M.H. James Functional changes in autonomic nervous responses with ageing Age Ageing 9 1980 17 24
10. P.A. Low Composite autonomic scoring scale for laboratory quantification of generalized autonomic failure Mayo Clin Proc 68 1993 748 752
11. A. Aniansson, C. Zetterberg, M. Hedberg Impaired muscle function with aging A background factor in the incidence of fractures of the proximal femur Clin Orthop Relat Res 191 1984 193 200
12. G. Grimby, A. Aniansson, M. Hedberg Training can improve muscle strength and endurance in 78 to 84 year old men J Appl Physiol 73 1992 2517-2423
13. R. Butler Did you say 'sarcopenia'? Geriatrics 48 1994 11 12
14. A. Aniansson, L. Sperling, A. Rundgren Muscle function in 75-year-old men and women. A longitudinal study Scand J Rehabil Med 9 Supp1 1983 92 102
15. C. Von de Bosch, M. Gilsing, S. Lee Peripheral neuropathy effect on ankle inversion and eversion Detectable thresholds Arch Phys Med Rehabil 76 1995 850 856
16. T. Postma, J. Heimans Grading chemotherapy-induced peripheral neuropathy Ann Oncol 11 2000 509 513
17. J.O. Holloszy, F.W. Booth Biochemical adaptations to endurance exercise in muscle Annu Rev Physiol 38 1976 273 291
18. E. Bruera, S. Carraro, E. Roca Double-blind evaluation of the effects of mazindol on pain, depression, anxiety, appetite, and activity in terminal cancer patients Cancer Treat Rep 70 1986 295 298
19. B. Ojala, L. Page, M. Moore Effects of inactivity on glycolytic capacity of single skeletal muscle fibers in adult and aged rats Biol Res Nurs 3 2001 88 95
20. D.M. Bonifati, C. Ori, C.R. Rossi Neuromuscular damage after hyperthermic isolated limb perfusion in patients with melanoma or sarcoma treated with chemotherapeutic agents Cancer Chemother Pharmacol 46 2000 517 522
21. T. Zima, V. Tesar, P.J. Richardson Effects of Doxorubicin (Adriamycin) and [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl) propane (ICRF-187) on skeletal muscle protease activities Toxicol Appl Pharmacol 171 2001 135 140
22. N. Tabata, R. Tanaka, S. Suga Rhabdomyolysis following administration of cyclophosphamide A case report in a BMT recipient Bone Marrow Transplant 17 1996 1167 1169
23. E. Shima, M. Hino, T. Yamane Acute rhabdomyolysis following administration of high-dose cyclophosphamide Case report Ann Hematol 81 2002 55 56
24. N.S. Tchekmedyian, D. Zahyna, C. Halpers Assessment and maintenance of nutrition in older cancer patients Oncology 6 supp1 1992 105 111
25. W. Demark-Wahnefried, E.P. Winer, B.K. Rimer Why women gain weight with adjuvant chemotherapy for breast cancer J Clin Oncol 11 1993 1418 1429
26. W. Demark-Wahnefried, B.L. Peterson, E.P. Winer Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy J Clin Oncol 19 2001 2381 2389
27. G. Parmigiani, D.A. Berry, E.P. Winer Is axillary lymph node dissection indicated for early-stage breast cancer? A decision analysis J Clin Oncol 17 1999 1465 1473
28. J.S. Mandelblatt, S.B. Edge, N.J. Meropol Predictors of long-term outcomes in older breast cancer survivors Perceptions versus patterns of care J Clin Oncol 21 2003 855 863
29. R. Silliman, N.M. Prout, T. Field Risk factors for a decline in upper body function following treatment for early stage breast cancer Breast Cancer Res Treat 54 1999 25 30
30. T. Lash, R. Silliman Long-term follow-up of upper body function among breast cancer survivors Breast J 8 2002 28 33
31. American College of Sports Medicine Position Stand Exercise and physical activity for older adults Med Sci Sports Exerc 30 1998 992 1008
32. C.E. Kasper, L. Sarna The influence of adjuvant chemotherapy on skeletal muscle and fatigue in women with breast cancer Biol Res Nurs 2 2000 133 139
33. National Cancer Institute. DCCPS surveillance research program, cancer statistics branch, surveillance, epidemiology, and end results (SEER) program public-use data 2001 National Cancer Institute Bethesda, MD
34. J.M. Guralnik Assessing the impact of comorbidity in the older population Ann Epidemiol 6 1996 376 380
35. J.S. Mandelblatt, A.S. Bierman, K. Gold Constructs of burden of illness in older patients with breast cancer A comparison of measurement methods Health Serv Res 36 2001 1085 1107
36. W.A. Satariano Comorbidity and functional status in older women with breast cancer Implications for screening, treatment, and prognosis J Gerontol 47 1992 24 31
37. J.S. Goodwin, W.C. Hunt, J.M. Samet Determinants of cancer therapy in elderly patients Cancer 72 1993 594 601
38. R. Yancik, M.N. Wesley, L.A. Ries Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older JAMA 285 2001 885 892
39. J.M. Elston, G.G. Koch, W.G. Weissert Regression-adjusted small area estimates of functional dependency in the noninstitutionalized American population age 65 and over Am J Public Health 81 1991 335 343
40. J.S. Goodwin, W.C. Hunt, J.M. Samet A population-based study of functional status and social support networks of elderly patients newly diagnosed with cancer Arch Intern Med 151 1991 366 370
41. J.A. Ajani, S.R. Welch, M.N. Raber Comprehensive criteria for assessing therapy-induced toxicity Cancer Invest 8 1990 147 159
42. R.S. Gelman, S.G. Taylor Cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in women more than 65 years old with advanced breast cancer The elimination of age trends in toxicity by using doses based on creatinine clearance J Clin Oncol 2 1984 1404 1413
43. H. Chen, A. Cantor, J. Meyer Can older cancer patients tolerate chemotherapy? A prospective pilot study Cancer 97 2003 1107 1114
44. A. Naeim, D. Reuben Geriatric syndromes and assessment in older cancer patients Oncology 15 1991 1567 1591
45. A. Jatoi, S. Hillman, P. Stella Daily activities Ex-ploring their spectrum and prognostic impact in older, chemotherapy-treated lung cancer patients Supp Care Cancer 11 2003 460 464